Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Quotient Sciences Acquires Pharmaterials
Quotient Sciences has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.
CVS Health launches state-by-state Impact Dashboard
A new online resource from CVS Health is showcasing the company’s impact on communities.
Health bodies test digital interventions for diabetes
NHS England, Public Health England and Diabetes UK have teamed up with leading companies from the tech sector to test new digital approaches to fighting type II diabetes.
New data show public support for tax rises to fund NHS
Fifty-eight percent of adults talking part in a YouGov poll have backed a one percent rise in National Insurance tax to increase public spend on the NHS.
FDA widens scope of Pfizer’s Sutent in kidney cancer
The US Food and Drug Administration has cleared Pfizer’s Sutent for adjuvant treatment of adults at a high risk of their kidney cancer returning after a kidney has been removed.
FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal
Today, the U.
Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health
One of the most promising fields of science is the area of cell-based therapies and their use in regenerative medicine.
FDA Approves Genentech’s HEMLIBRA (emicizumab-kxwh) for Hemophilia A with Inhibitors
SOUTH SAN FRANCISCO, Calif.
FDA approves treatment for rare genetic enzyme disorder
The U.
With new digital Abilify, big brother isn't watching—but your mother could be
A new digital version of Abilify is the first-ever pill to notify patients that they've swallowed it.
Merck, GlaxoSmithKline face hepatitis A vaccine shortage amid U.S. outbreaks
It was only August when Merck and GlaxoSmithKline had to deal with a global shortage for their hepatitis B vaccines, and now unexpected demand in the U.
With only 2 warnings in 2017, pharma's ad police hits historic low
As the end of the year nears, the pharma industry can usually look back at FDA enforcement letters for insight into the agency's thinking and guidance on marketing communications.
500
501
502
503
504
505
506
507
508
